Unstable angina: New insights into pathophysiologic characteristics, prognosis, and management strategies

Current Problems in Cardiology

Volumn 21, Issue 10, 1996, Pages 669-731

  Ribeiro, Paulo A ^a   Shah, Pravin M ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; FORECASTING; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CLINICAL TRIALS; FORECASTING; HUMANS; PROGNOSIS;

EID: 0030253327     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0146-2806(96)80004-1     Document Type: Article

References (241)

1. Sampson JJ, Eliaser M. The diagnosis of impending acute coronary artery occlusion. Am Heart J 1937;13:675-86.
2. Freedberg AS, Blumgart HL, Zoll PM, Schlesinger MJ. The clinical syndrome of cardiac pain intermediate between angina pectoris and acute myocardial infarction. JAMA 1948; 138(2): 107-14.
3. Beamish RE, Storrie VM. Impending myocardial infarction. Circulation 1960;XXI:1107-15.
4. Wood P. Acute and subacute coronary insufficiency. BMJ 1961;5242:1779-82.
5. Vakil RJ. Preinfarction syndrome-management and follow-up. Am J Cardiol 1964;14:55-63.
6. Russell RO, Moraski RE, Kouchoukos N, et al. Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy. Am J Cardiol 1980;45:819-24.
7. Braunwald E. Unstable angina. Circulation 1989;80(2):410-4.
8. Constantinides P. Plaque fissures in human coronary thrombosis. J Atheroscler Res 1966;6:1-17.
9. Davies JM, Thomas AC. Thrombosis and acute coronary artery lesion in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-40.
10. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-73.
11. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73:418-27.
12. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990;82(Suppl II):II38-II46.
13. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985:71:699-708.
14. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol 1989;63:114E-20E.
15. Chesebro JH, Zoldhelyi P, Fuster V. Plaque disruption and thrombosis in unstable angina pectoris. Am J Cardiol 1991;68:9C-15C.
16. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis: evolving concepts. Circulation 1990;82(Suppl II):47-59.
17. Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis 1986:6:585-93.
18. Parsons TJ, Haycraft DL. Hoak JC. Sage H. Interaction of platelets and purified collagens in a laminar flow model. Thromb Res 1986:43:435-43.
19. Drake TA. Morissey JH. Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorder of hemostasis and thrombosis. Am J Pathol 1989:134:1087-97.
20. Drake TA, Morrissey JH. Edgington TS. Immunohistochemical detection of tissue factor in human atherosclerotic plaques. Circulation 1989:80(Suppl II):82-6.
21. Fernandez-Ortiz A. Badimon J. Falk E. et al. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994:23:1562-9.
22. Davies MJ. Richardson PD, Woolf N, Katz DR. Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993:69:377-81.
23. Badimon L. Badimon JJ, Turitto VT. Vallabhajosula S. Fuster V. Platelet thrombus formation of collagen type I: a model of deep vessel injury, influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation 1988:78:1432-42.
24. Badimon E, Badimon JJ. Mechanism of arterial thrombosis in non-parallel streamlines: platelet thrombi grow at the apex of stenotic severely injured vessel wall: experimental study in the pig model. J Clin Invest 1989;84:1134-44.
25. EassilaR, Badimon JJ, Vallabhajosula S. Badimon E. Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood: effects of different stenosis on thrombus growth. Arteriosclerosis 1990:10:306-15.
26. Fuster V. Badimon E. Cohen M, Ambrose JA. Badimon JJ. Chesebro JH. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988:77:1213-20.
27. Chesebro JH, Zoldhelyi P, Fuster V. Pathogenesis of thrombosis in unstable angina. Am J Cardiol 1991;68:2B-10B.
28. Falk E, Oriz-Fernandez A. Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 1995:75:56-1 IB.
29. Badimon E. Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992;86(Suppl III):74-5.
30. Davies MJ. Thrombosis and coronary atherosclerosis. In: Julian DG. editor. Thrombolysis in cardiovascular disease. New York: Marcel Dekker, 1989:25-43.
31. Holmes DR, Hartzier GO, Smith HC, FusterV. Coronary artery thrombosis in patients with unstable angina. Br Heart J 1981:45:411-6.
32. Gotoh K. MinaminoT. KatohO. et al. The role of intracoronary thrombus in unstable angina: angiographie assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 1988:77:526-34.
33. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol 1987:18:11-6.
34. Vermylen J. Verstraete M, Fuster V. Role of platelet activation and fibrin formation in thrombogenesis. J Am Coll Cardiol 1986:8:20-80.
35. Zalewski A, Shi Y, Nardone D, et al. Evidence of reduced fibrinolytic activity in unstable angina at rest. Circulation 1991:83:1685-91.
36. Ambrose JA, Tannenbaum MA, Alexoupoulo S. Angiographie progression of coronary artery disease and the development of myoeardial infarction. J Am Coll Cardiol 1988:12:56-62.
37. Ambrose JA, Winters SE, Arora RR. Angiographie evaluation of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986:7:472-8.
38. Moreno PR, Falk E. Palacios IF, Newell JB. Fuster V. Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994:90:775-8.
39. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaque. Circulation 1995:92:1565-9.
40. Kohchi K, Takebayashi S, Hiroki T, Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation 1985;71:709-16.
41. Sato T, Takebayashi S, Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina: histological data on 14 autopsied patients. Atherosclerosis 1987:68:191-7.
42. Carry M, Korley V, Willerson JT, Weigelt L, Ford-Hutchinson AW, Tagari P. Increased urinary leukotriene excretion in patients with cardiac ischemia: in vivo evidence of 5-lipooxygenase activation. Circulation 1992:85:230-6.
43. Ciabattoni G, Ujang S, Sritara P, et al. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization on coronary angioplasty. J Am Coll Cardiol 1993:21:1377-81.
44. Serneri GG, Abbate R, Gori AM, et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 1992;86:790-7.
45. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994:331:417-24.
46. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989:2:941-4.
47. Loree HM, Kamm RD, Stringfellow RD, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res 1992:71:850-8.
48. Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions: a structural analysis with histopathologic correlation. Circulation 1993;87:1179-87.
49. Lee RT, Kamm RD. Vascular mechanics for the cardiologist. J Am Coll Cardiol 1994:23:1289-5.
50. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995:92:657-71.
51. Libby P. Inflammatory and immune mechanisms in atherogenesis. In: Leaf A, Weber PC, editors. Atherosclerosis reviews. New York: Raven, 1990:79-89.
52. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995:91:2844-50.
53. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinasis and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994:94:2493-503.
54. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U SA 1991:88:8154-8.
55. Falk E. Why do plaques rupture? Circulation 1992:86:11130-42.
56. Francis CW, Markham RE, Barlow GH, Florack TM, Dorbrzynski DM, Marder VJ. Thrombin activity of fibrin thrombi and soluble plasmic deviates. J Lab Clin Med 1983:102:220-30.
57. Chesebro JH, Webster MWI, Zoldhelyi P, Roche PC, Badimon L, Badimon JJ. Antithrombotic therapy and progression of coronary artery disease. Circulation 1992;86(Suppl III):100-11.
58. Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGx-PGI2) by layers of the arterial wall: an explanation for the antithrombotic properties of vascular endothelium. Thromb Res 1977;11:323-44.
59. Radmonski MW, Palmer MJ, Moncada S. The role of nitrous oxide and cGMP in platelet adhesion to the endothelium. Biochem Biophys Res Commun 1987:148:1482-9.
60. Lam JYT, Chesebro JH. Steele PM, Badimon L. Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 1987:75:243-8.
61. Vanhoutte PM. Shimokawa H. Endothelium derived relaxing factor and coronary vasospasm. Circulation 1989:80:1-9.
62. Steele PM. Chesebro JH, Stanson AW, et al. Balloon angioplasty: natural history of ihe pathophysiology response to injury in a pig model. Circ Res 1985:57:105-12.
63. Fuster V. Badimon L. Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992:326:310-8.
64. Chierchia S. Brunelli C. Simonetti I, Lazzari M. Maseri A. Sequence of events in angina at rest: primary reduction in coronary flow. Circulation 1980:61:759-68.
65. Zeiher AM. Goebel H. SchachingerV, IhlingC. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995:91:941-7.
66. Yang Z, Richard D. Von Seggesser L. et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm? Circulation 1990:82:188-95.
67. Tabuchi Y. Nakamura M, Rakugi H, Nagano M, Ogihara T. Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem Biophys Res Commun 1989:159:1304-8.
68. Dohi Y. Hahn AWA, Boulanger CM. Büler FR. Lüscher TF. Endothelin stimulated angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992:19:131-7.
69. Ehrenreich H. Anderson RW. Fox CH. et al. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990:172:1741-8.
70. Qiao JH, Fishbein MC. The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombus. J Am Coll Cardiol 1991:17:1138-42.
71. Mruk JS. Chesebro JH, Webster MWI. Platelet aggregation and interaction with the coagulation cascade system: implications for antithrombotic therapy in arterial thrombosis. Coronary Artery Dis 1990:1:149-58.
72. Mann KG, Tracy PB. Nesheim NE. Assembly and functions of prothrombinases complex on synthetic and natural membranes. In: Oates JA Jr, Harwiger J. Ross R. editors. Interaction of platelets with vessel wall. Washington DC: American Physiology Society 1985:47.
73. Haerem JW. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. Atherosclerosis 1974; 19:529-41.
74. El-Maraghi N. Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980:62:936-44.
75. Shah PK. Pathophysiology of unstable angina. Cardiol Clin 1991;9:11-26.
76. Barger A. Beeskes IR, Eainey E, Silverman K. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984;310:175-7.
77. Geiringer E. Intimai vascularization and atherosclerosis. J Pathol Bacteriol 1951:63:201-11.
78. Paterson JC. Vascularization and hemorrhage of the intima of arteriosclerotic coronary arteries. Arch Pathol 1936:22:313-24.
79. Paterson JC. Capillary rupture with intimai hemorrhage as a causative factor in coronary thrombosis. Arch Pathol 1938:25:474-87.
80. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Eewis A. Conner Memorial Eecture. Circulation 1994;90:2126-46.
81. Ambrose JA, Douglas HI. Angiography in unstable angina. Am J Cardiol 1991;68:78B-84B.
82. Moise A, Theroux, P, Taeymans Y, et al. Unstable angina and progression of coronary atherosclerosis. N Engl J Med 1983;309:685-9.
83. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kashi JC. Angiographie stenosis progression and coronary events in patients with stabilized unstable angina. Circulation 1995;91:2319-24.
84. Theroux P. Angiographie and clinical progression in unstable angina from clinical observations to clinical trial. Circulation 1995;91:2295-8.
85. Hangartner JRW, Chaleston AJ, Davies MJ, Thomas AC. Morphologic characteristics of clinically significant coronary artery stenosis in stable angina. Br Heart J 1986;56:501-8.
86. Nissen SE, Gurley JC, Grines CL, et al. Intravascular ultrasound assessment of lumen site and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991;84:1087-99.
87. Ge J, Erbel R, Gerber T, et al. Intravascular ultrasound imaging of angiographically normal coronary arteries: a prospective study in vivo. Br Heart J 1994;71:572-8.
88. Nissen SE, Curley JC, Booth DC, et al. Differences in intravascular ultrasound morphology in stable and unstable patients [abstract]. Circulation 1991;85:II436.
89. Perlman JD, Southern JF, Ackerman JI. Nuclear magnetic resonance microscopy of atheroma in human coronary arteries. Angiology 1991;42:726-33.
90. Liebson PR, Klein LW. Intravascular ultrasound in coronary atherosclerosis: a new approach to clinical assessment. Am Heart J 1992;123:1643-50.
91. Group SSSS. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease: the Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-9.
92. Helsinki Heart Study. Primary prevention trial with gemfibrozil in middle aged men with dyslipidemia: safety of treatment, changes in risk factors and incidence of coronary disease. N Engl J Med 1987;317:1237-45.
93. Brown BG, Zao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993:87:1781-91.
94. Kane JP, Malloy MJ, Ports TA, et al. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
95. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990:323:1289-98.
96. Brensike JF, Levy RI, Kelsey SF, et al. Effects of therapy with cholestyramine on progression of coronary atherosclerosis: results of the NHLBI/Type II Coronary Intervention Study. Circulation 1984;69:313-24.
97. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in cholesterol fed rabbits. J Clin Invest 1990;85:1234-41.
98. Blankenhorn DH, Kramsch DM. Reversal of atherosis and sclerosis: the two components of atherosclerosis. Circulation 1989;79:1-7.
99. Yusuf S, Peto J, Lewis J, et al. Beta-blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985:27:335-71.
100. Frishman WH, Lazer EJ. Reduction in mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade. Am J Cardiol 1990;66:66G-70G.
101. Multicentre International Study. Supplementary report: reduction in mortality after tnyocardial infarction with long term beta-adrenoreceptor blockade. Br Med J 1971:2:419-21.
102. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992:327:685-91.
103. Constantinides P. Ultrastructural injury of arterial endothelium: II. Effects of vasoactive amines. Arch Pathol 1969:88:106-17.
104. Constantinides P. Causes of thrombosis in human atherosclerotic arteries. Am J Cardiol 1990;66:37C-40C.
105. Chisolm G. Antioxidants and atherosclerosis: a current assessment. Clin Cardiol 1991:14:125-30.
106. Jessup W, Dena RT, de WC, et al. The role of oxidative modification and antioxidants in EDL metabolism and atherosclerosis. Adv Exp Med Biol 1990:264:139-42.
107. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effects of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA 1987:84:7725-9.
108. Esterbauer H, Puhl H. Dieber R, etal. Effect of antioxidants on oxidative modification of LDE. Ann Med 1991:23:573-81.
109. Eendon CL, Davies MJ, Born GVR. Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991:87:87-90.
110. Clinton S, Underwood R, Sherman M, Kufed D, Libby P. Macrophage colony stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. Am J Pathol 1992:140:310-6.
111. Ambrose JA. Winters JE, Stern A, et al. Angiographie morphology and the pathogenesis of unstable angina. J Am Coll Cardiol 1985:5:609-16.
112. 12. Ambrose JA, Hjemdahl-Monsen CE. Arteriographie anatomy and mechanisms of myocardial ischemia in unstable angina. J Am Coll Cardiol 1987:9:1397-402.
113. Furling B, HendersonAH, Eewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol 1987:90:687-92.
114. Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987:90:181-7.
115. McAlpin RN. Contribution of dynamic vascular wall thickening to luminal narrowing during coronary artery constriction. Circulation 1980:60:296-301.
116. Collins P, Fox KM. Pathophysiology of angina. Lancet 1990:335:94-7.
117. Davies MJ, Bencivelli W, Frangasso G, et al. Sequence and magnitude of ventricular volume changes in painful and painless myocardial ischemia. Circulation 1988:310:78-83.
118. Bogaty P, Hacket D, Davies G. Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1987:76:243-8.
119. Genova M, Barta E. Gero J. Sympathetic control of major coronary artery diameter in the dog. Circ Res 1979:44:459-67.
120. Nadeau RA, de Champlain J. Plasma catecholamines in acute myocardial infarction. Am Heart J 1979:98:548-54.
121. Muller JE, Abel GS. Nesto RS. Tofler GH. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 1994:23:809-13.
122. Yeung AC. Vekshtein VI. Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991:325:1551-6.
123. Fuster V. Chesebro JH. Frye RE. Elveback ER. Platelet survival and development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history, and medical therapy. Circulation 1981:63:545-51.
124. Winniford MD, Wheeland KR, Kremers MS, et al. Smoking induced coronary vasoconstriction in patients with atherosclerotic heart disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986;73:662-7.
125. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JF. Triggering of acute myocardial infarction by heavy physical exertion. N Engl J Med 1993:329:1677-83.
126. Moliterno DJ, Willard JF, Lange RA, et al. Coronary artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994:330:454-9.
127. Neil WA, ShartonTP, Fluri-Lundeen J, Cohen IS. Acute coronary insufficiency-coronary occlusion after intermittent ischemie attacks. N Engl J Med 1980:302:1157-62.
128. Bini A, Fenoglio JJ, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin (ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis 1989;9:109-21.
129. Davies M, Bland J, Hangartner J, et al. Factors influencing the presence or absence of acute coronary thrombi in sudden ischemie death. Eur Heart J 1989:10:203-8.
130. Roberts WC, Buja LM. The frequency and significance of coronary arterial thrombi and other observation in fatal myocardial infarction. Am J Med 1972:52:425-43.
131. National Center for Health Statistics. Detailed diagnosis and procedures for patients discharged from short stay hospitals. Hyattsville, MD: US Department of Health and Human Services, Public Health Services, Series 13, no. 90, 1987.
132. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985:71:699-708.
133. Harper RW, Kennedy G, De Sanctis RW, Hotter AM. The incidence and pattern of angina prior to acute myocardial infarction: a study of 577 cases. Am Heart J 1979:97:178-83.
134. Gazes PC, Mobley EM Jr, Paris HM Jr, et al. Preinfarction (unstable) angina: a prospective study-ten year follow-up: prognostic significance of electrocardiographic changes. Circulation 1973;48:331-7.
135. Langer A, Freeman MR, Armstrong PW. ST-segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989:13:1495-502.
136. Plotnic GD, Conti CR. Transient ST segment elevation in unstable angina: clinical and hemodynamic significance. Circulation 1975;5:1015-9.
137. Prinzemetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris: a variant form of angina pectoris. Am J Med 1959:27:375-88.
138. Maseri A, Severi S, De Ives M, et al. Variant angina: one aspect of continuous spectrum of vasospastic myocardial ischemia: pathogenetic mechanisms, estimated incidence and clinical and coronary angiographie findings in 138 patients. Am J Cardiol 1978;42:1019-23.
139. Waters DD, Miller DD, Szlachcic J, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation 1983;68:258-65.
140. Weiner L, Kasparian H, Duca PR, et al. Spectrum of coronary arterial spasm: clinical, angiographie and myocardial metabolic experience in 29 cases. Am J Cardiol 1976:38:945-9.
141. Miller DD, Waters DD, Szachcic J, et al. Clinical characteristics associated with sudden death in patients with variant angina. Circulation 1982:66:588-92.
142. Miwa K, Kambara H, Kawai C. Effect of aspirin in large doses on attacks of variant angina. Am Heart J 1983:105:351-7.
143. Nademanee K, Intrarachot V, Singh PN, Josephson MA, Singh BN. Characteristics and clinical significance of silent myocardial ischemia in unstable angina. Am J Cardiol 1986;58:26B-33B.
144. Deanfield J, Maseri A, Selwyn AP, Ribeiro P. et al. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 1983;2:753-8.
145. Deanfield JE, Shea M, Ribeiro P, et al. Transient ST-segment depression as a marker of myocardial ischemia during daily life. Am J Cardiol 1984;54:1195-2000.
146. Nademanee K, Intrarachot V, Josephson MA, Rieders D, Mody FV, Singh BN. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987; 10:1-9.
147. Gottlieb S, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214-9.
148. Gerhardt W, Waldenstrom J, Horder M, et al. Creatinine kinase and creatinine Bsubunit activity in sérum in cases of suspected myocardial infarction. Clin Chem 1982;28:277-83.
149. White RD, Grande P, Califf L, Palmeri ST, Califf RM, Wagner GS. Diagnostic and prognostic significance of minimally elevated creatinine kinase-MB in suspected acute myocardial infarction. Am J Cardiol 1985:55:1478-88.
150. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
151. McNeer JF, Margoli JR. Lee KL, et al. The role of the exercise test in the evaluation of patients for ischemie heart disease. Circulation 1978;57:64-70.
152. Butman SM, Olson HG, Butman LK. Early exercise testing after stabilization of unstable angina: correlation with coronary angiographie findings and subsequent cardiac events. Am Heart J 1986;111:11-8.
153. Coplan NL, Wallach ID. The role of exercise testing for evaluating patients with unstable angina. Am Heart J 1992; 124:252-6.
154. Severi S, Orsini E, Marraccini P, et al. The basal electrocardiogram and the exercise stress test in assessing prognosis in patients with unstable angina. Eur Heart J 1988:4:441-5.
155. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmentai wall motion abnormalities in patients with unstable angina by twodimensional echocardiography. Circulation 1982:65:1497-503.
156. Freeman MR, Williams AE, Chisholm RJ, Patt NL, Greyson ND, Armstrong PW. Role of resting thallium perfusion in predicting coronary anatomy, left ventricular wall motion and hospital outcome in unstable angina pectoris. Am Heart J 1989:117:306-14.
157. Younis LT, Byers S, Shaw L, et al. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemie event. Am J Cardiol 1989:64:161-5.
158. Williams AE, Freeman MR, Chisholm RJ, Patt NL, Armstrong PW. Angiographie morphology in unstable angina pectoris. Am J Cardiol 1988:62:1024-7.
159. Levin DC, Fallen JT. Significance of the angiographie morphology of localized coronary stenosis: histopathologic correlation. Circulation 1982;66:316-20.
160. Allison HW, Russel RO Jr, Mantle JA, Kouchoukos NT, Moraski RE, Rackley CE. Coronary anatomy and arteriography in patients with unstable angina pectoris. Am J Cardiol 1978:41:204-9.
161. Bugiardini R, Pozzati A, Borgh IA, et al. Angiographie morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Cardiol 1991:62:460-5.
162. McCormick JR. Schick EC, McCabe CH, et al. Determinants of operative mortality and long-term survival in patients with unstable angina: the CASS experience. J Thorac Cardiovasc Surg 1985:89:683-8.
163. Capone G, Wolf NM. Meyer B. Meister SG. Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol 1985;56:403-6.
164. Vetrovec GM, Cowley MJ, Overton H, Richardson DW. Intracoronary thrombus in syndromes of unstable myocardial ischemia. Am Heart J 1981;102:1202-8.
165. Zack PM, Isheinger T, Oker VT, Dincer B, Kennedy HL. The occurrence of angiographie detected intracoronary thrombus in patients with unstable angina pectoris. Am Heart J 1984;108:1408-11.
166. Ambrose J, Wintus S, Stern A, Eng A, Teichlolz LE, Fuster V. Angiographie morphology in unstable angina. J Am Coll Cardiol 1984;3:490-4.
167. Freeman MR, Williams AE, Chisholm RJ, Armstrong PW. Intracoronary thrombus and complex morphology in unstable angina: relation to timing of angiography and in-hospital cardiac events. Circulation 1989;80:17-23.
168. Fischl SJ, Herman MV, Gorlin R. The intermediate coronary syndrome: clinical, angiographie and therapeutic aspects. N Engl J Med 1973;288:1193-8.
169. Roberts KB, Califf RM, Harrell FE Jr, et al. The prognosis for patients with new onset angina who have undergone cardiac catheterization. Circulation 1983;68:670-7.
170. Sherman CT, Litvack F, Grondfest W, et al. Coronary angioscopy in patients with unstable angina. N Engl J Med 1986;315:913-9.
171. Mizuno K, Satomura K, Miyamoto A, et al. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes. N Engl J Med 1992;326:287-91.
172. Pasternack RC, Braunwald E, Sobel BE. Acute myocardial infarction. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 3rd éd. Vol 2. Philadelphia: WB Saunders, 1988:1222-31.
173. Uchida Y, Masuo M, Tomaru T, Kato A, Sugimoto T. Fiberoptic observation of thrombosis and thrombolysis in isolated human coronary arteries. Am Heart J 1986;112:691-6.
174. Badimon L, Lassila R, Badimon JJ, Vallabhajosula S, Chesebro JH, FusterV. Residual thrombus is more thrombogenic than severely damaged vessel wall. Circulation 1988;78(Suppl II):II-119.
175. Mann KG, Tracy PB, Nesheim ME. Assembly and function of prothrombinase complex on synthetic and natural membranes. In: Oates JA Jr, Harwiger J, Ross R, editors. Interaction of platelets with the vessel wall. Washington, DC: American Physiology Society, 1985:47-57.
176. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
177. Hirsh J, Fuster V. Guide to anticoagulant therapy: Part 1: Heparin. Circulation 1994;89:1449-68.
178. RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary disease. Lancet 1990;336:827-30.
179. Theroux P, Ouimet H, McCan S. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
180. Weitz JI, Hudoba D, Massel D, Maraganore J, Hirsh J. Clot bound thrombin is protected from inhibition by heparin antithrombin III but is susceptible to inactivation by anti-thrombin III independent inhibitors. J Clin Invest 1990;86:385-91.
181. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992;327:141-5.
182. Calvin J, Vandenberg B, Ramirez-Morgan L, Klien L. Heparin therapy duration beyond 48 hours: benefit or detriment in unstable angina [abstract]. Circulation 1994:;0:1-29.
183. Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest 1992;102:352S-63S.
184. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Strinivas S. The weight-based heparin dosing nomogram compared with standard care nomogram. Ann Intern Med 1993;119:874-81.
185. Fuster V. Dyken ML, Vokonas PS, Hennekens C. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1993;87:659-75.
186. Stein B, Fuster V. Clinical pharmacology of platelet inhibitors. In: Fuster V, Verstraete M, editors. Thrombosis in cardiovascular disorders. Philadelphia: WB Saunders, 1992:99-120.
187. Theroux P, Waters D, Qiu S, McCans J, Guise PD, Juneau M. Aspirin versus heparin to prevent myocardial infarction during acute phase of unstable angina. Circulation 1993;88(1):2045-8.
188. Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non Q-wave infarction in non-prior aspirin users: primary end point analysis from the ATACS trial. Circulation 1994;89:81-8.
189. Fuster V, Jang IK. Role of platelet inhibitor agents in coronary artery disease. In: Topol EJ, editor. Textbook of interventional cardiology. 2nd ed. Philadelphia: WB Saunders, 1994:3-23.
190. Clowes AW, Karnovsky MJ. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab Invest 1977:36:452-64.
191. Cairns JA, Gent M, Singer J, et al. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985;313:1369-72.
192. Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: result of VA cooperative study. N Engl J Med 1983:309:396-403.
193. O'Brein JR. Ticlopidine, a promise for the prevention and treatment of thrombosis and its complications. Haemostasia 1983:113:1-54.
194. Balsano F, Rizzon P, Violi F, et al. Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter trial. Circulation 1990:82:17-26.
195. Stamler J, Cunningham M, Loscalzo J. Reduced thiols and the effects of intravenous nitroglycerin on platelet aggregation. Am J Cardiol 1988:62:377-83.
196. Cappuro NL, Kent KM, Epstein SE. Comparison of nitroglycerin, nitroprusside and phentolamine induced changes in coronary collateral function in dogs. J Clin Invest 1977:60:295-301.
197. Kaplan K, Davidson R, Parker M, Przygylek J, Teagarden JR, Lesch M. Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy. Am J Cardiol 1983:51:694-8.
198. Shu-Guang L, Flaherty JT. Crossover from intravenous to transdermal nitroglycerin therapy in unstable angina pectoris. Am J Cardiol 1985:56:742-8.
199. Jugdutt BI, Warnica JW. Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction. Am J Cardiol 1989:64:581-6.
200. Frishman WH. Beta adrenoreceptors antagonists: new drugs and new indications. N Engl J Med 1981:305:500-6.
201. Morris RM, Clarke ED, Sammel NL, et al. Protective effect of propranolol in threatened myocardial infarction. Lancet 1987;2:907-9.
202. Telford AM, Wilson C. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome. Lancet 1981:1:1225-8.
203. Gottlieb O, Weisfeldt ML, Ouyang P, et al. Effect of the addition of propranolol therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Circulation 1986:73:331-6.
204. Lubsen J, Tijssen JGP, for the HINT Research Group. Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT). Am J Cardiol 1987:60:181-251.
205. Theroux P, Taeymans Y, Morissette D, Bosch X, Pelletier GB, Waters DD. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol 1985:5:717-22.
206. Wallis DE, Pope C, Littman WJ, Schanlon PJ. Safety and efficacy of esmolol for unstable angina pectoris. Am J Cardiol 1988;62:1033-7.
207. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989;229:1187-92.
208. Fang ZY, Picart N, Abramowicz M, et al. Intravenous diltiazem versus nitroglycerin for silent and symptomatic myocardial ischemia in unstable angina pectoris. Am J Cardiol 1991;68:42C-6C.
209. Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation 1984;69:740-7.
210. Lefkovits J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation 1994;90:1522-36.
211. Markwardt F. Development of hirudin as an antithrombotic agent. Semin Thromb Hemost 1989;15:269-82.
212. Lidon R, Theroux P, Juneau M, Adelman B, Maraganore J. Initial experience with a direct antithrombin, hirulog, in unstable angina: anticoagulant, antithrombotic and clinical effects. Circulation 1993;90:1631-7.
213. Topol EJ, Fuster V, Harrington RA, et al. Recombinant hirudin for unstable angina pectoris: a multicenter, randomized angiographie trial. Circulation 1994;89:1557-66.
214. Fuchs J, McCabe CH, Antman EM, et al. Hirulog in the treatment of unstable angina: results of the TIMI 7 trial [abstract]. J Am Coll Cardiol 1994;23:56A.
215. Freeman MR, Langer A, Wilson RF, Morgan CD, Armstrong PW. Thrombolysis in unstable angina: randomized double-blind trial of t-PA and placebo. Circulation 1992;85:150-7.
216. Bar FW, Verheugt FW, Col J, et al. Thrombolysis in patients with unstable angina improves the angiographie but not the clinical outcome. Circulation 1992;86:131-77.
217. Schreiber TL, Rizik D, White C, et al. Randomized trial of thrombolysis versus heparin in unstable angina. Circulation 1992;86:1407-14.
218. TIMI III B Trial of thrombolysis in unstable angina and non Q-wave myocardial infarction. American Heart Association meeting 1992, New Orleans.
219. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER. Thrombolytic therapy with tissue plasminogen activation or streptokinase induces transient thrombin activity. Blood 1988;72:616-20.
220. Topol EJ. Thrombolytic intervention. In: Topol EJ, editor. Textbook of interventional cardiology. 2nd ed. Philadelphia: WB Saunders, 1994:68-111.
221. Williams DO, Topol EJ, Califf RM, et al. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 1990;82:376-83.
222. Knudsen ML. Clinical management of unstable angina: the place of antithrombins and platelet GP Ilb/IIIa receptor blockers. Eur Heart J 1995;16 Suppl:68-74.
223. Simoons ML, De Boer J, Van den Brand MJBM, et al. Randomized trial of a GP lib/ Ilia platelet receptor blocker in refractory unstable angina. Circulation 1994;89:596-603.
224. Timmis AD, Griffin B, Crick JCP, et al. Early percutaneous transluminal coronary angioplasty in the management of unstable angina. Int J Cardiol 1987;14:25-9.
225. De Feyter PJ, Serruys P. Percutaneous transluminal coronary angioplasty for unstable angina. In: Topol EJ, editor. Textbook of interventional cardiology. 2nd ed. Philadelphia: WB Saunders, 1994:274-91.
226. Plokker HWT, Ernst SMPG, Bale T, et al. Percutaneous transluminal coronary angioplasty of one vessel for refractory unstable angina pectoris: efficacy in single and multivessel disease. Cathet Cardiovasc Diagn 1988;14:15-9.
227. Perry RA, Seth A, Hunt A, et al. Coronary angioplasty in unstable angina and stable angina: a comparison of success and complications. Br Heart J 1988;60:367-74.
228. Myler RK. Shaw RE, Stertzer SH, et al. Unstable angina and coronary angioplasty. Circulation 1990:82(Suppl II):II-88.
229. Rupprecht JH, Brennecke R, Kottomeyer M, et al. Short and long term outcome after PICA in patients with stable and unstable angina. Eur Heart J 1990;11:964-72.
230. Califf RM, Lincoff AM. Tcheng JE, Topol EJ. An overview of the results of the EPIC trial. Eur Heart J 1995;16(Suppl L):43-9.
231. Luchi RJ, Scott SM, Deupree RH, et al. Comparison of medical and surgical treatment for unstable angina. N Engl J Med 1987 ;316:977-81.
232. Goldman HE, Weisel RD, Christakis G. et al. Predictors of outcome after coronary artery bypass graft surgery to stable and unstable angina pectoris. In: Hugenholtz PG, Goldman BJ. editors. Unstable angina-current concepts and management. New York: Schaltaver-Stuttgart, 1985:319-29.
233. Ahmed M, Thompson R, Seabra-Gomes R. et al. Unstable angina: a clinicoarteriographic correlation and long term results of early myocardial revascularization. J Thorac Cardiovasc Surg 1980:79:609-15.
234. Brawley RK, Merril W, Gott VL, et al. Unstable angina pectoris: factors influencing operative risk. Ann Surg 1980:19:745-9.
235. Parisi AF, Khuri S. Deupree RH, et al. Medical compared with surgical management of unstable angina: five year mortality and morbidity in the Veterans Administration Study. Circulation 1989;80:1178-82.
236. McCormick JR, Schick EC. McCabe CH. Kronmal RA, Ryan TJ. Determinants of operative mortality and long term survival in patients with unstable angina. J Thorac Cardiovasc Surg 1985:89:683-8.
237. Sclarovsky S. Rechavia E, Strasberg B, et al. Unstable angina: ST segment depression with positive versus negative T wave deflections-clinical course, ECG evolution, and angiographie correlation. Am Heart J 1988:116(4):933-41.
238. Haines DE. Raabe DS. Gundel WD. Wackers FJ. Anatomic and prognostic significance of new T-wave inversion in unstable angina. Am J Cardiol 1983:52:14-8.
239. Karlson BW. Herlitz J. Pettersson P. Hallgren P. Strombom U. Hjalmarson A. Oneyear prognosis in patients hospitalized with a history of unstable angina pectoris. Clin Cardiol 1993:16:397-402.
240. Nyman I. Areskog M, Areskog NH, Swahn E. Wallentin L. Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease. J Intern Med 1993:234:293-301.
241. Langer A. Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989:13(7): 1495-502.